Published in Bull Acad Natl Med on October 01, 1990
Adult brain abscess associated with patent foramen ovale: a case report. J Med Case Rep (2007) 0.92
Potential new uses of non-vitamin K antagonist oral anticoagulants to treat and prevent stroke. Neurology (2015) 0.75
Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med (2009) 7.53
Second consensus statement on the diagnosis of multiple system atrophy. Neurology (2008) 7.27
Right ventricular dysplasia: a report of 24 adult cases. Circulation (1982) 6.54
Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology (2006) 6.44
Prevalence of patent foramen ovale in patients with stroke. N Engl J Med (1988) 5.94
Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease. Lancet (2004) 5.06
Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med (2000) 4.98
Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet (1999) 4.74
Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell (1998) 4.41
Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet (1996) 3.26
Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet (1997) 3.11
Predominant dystonia with marked cerebellar atrophy: a rare phenotype in familial dystonia. Neurology (2006) 3.07
Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet (1997) 2.77
Clinical pharmacology and therapeutic applications of the antiarrhythmic agent amiodarone. Am Heart J (1981) 2.41
Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet (2000) 2.40
Frequency of the DYT1 mutation in primary torsion dystonia without family history. Arch Neurol (2000) 2.17
The natural history of spinocerebellar ataxia type 1, 2, 3, and 6: a 2-year follow-up study. Neurology (2011) 2.06
Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol (1999) 2.02
A third locus for autosomal dominant cerebellar ataxia type I maps to chromosome 14q24.3-qter: evidence for the existence of a fourth locus. Am J Hum Genet (1994) 1.76
[Electrocardiology of 4 cases of right ventricular dysplasia inducing arrhythmia]. Arch Mal Coeur Vaiss (1978) 1.69
Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet (1998) 1.64
Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum Mol Genet (1998) 1.56
Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. Neurology (2008) 1.53
Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p. Hum Mol Genet (1994) 1.49
Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology. Eur J Hum Genet (2000) 1.47
[Beta-blockers in the treatment of heart failure]. Presse Med (1990) 1.39
[Arrhythmogenic right ventricular dysplasia and Uhl's disease]. Arch Mal Coeur Vaiss (1982) 1.38
Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations? Brain (2000) 1.36
Left coronary artery aneurysm and anteroseptal acute myocardial infarction following blunt chest trauma. Eur Heart J (1986) 1.27
The gene for autosomal dominant cerebellar ataxia with pigmentary macular dystrophy maps to chromosome 3p12-p21.1. Nat Genet (1995) 1.26
Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet (1997) 1.24
SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years. Neurology (2006) 1.22
Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology (2008) 1.21
SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann Neurol (2001) 1.20
[Nosologic frontiers of arrhythmogenic dysplasia. Quantitative variations of normal adipose tissue of the right heart ventricle]. Arch Mal Coeur Vaiss (1991) 1.19
Analysis of the SCA1 CAG repeat in a large number of families with dominant ataxia: clinical and molecular correlations. Ann Neurol (1995) 1.16
Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia 3/Machado-Joseph disease locus. Am J Hum Genet (1995) 1.15
A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24-q34. Am J Hum Genet (2000) 1.14
Recombinations in individuals homozygous by descent localize the Friedreich ataxia locus in a cloned 450-kb interval. Am J Hum Genet (1994) 1.14
Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias. Neurology (2002) 1.13
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. Am J Hum Genet (2001) 1.13
Muscle coenzyme Q10 deficiencies in ataxia with oculomotor apraxia 1. Neurology (2007) 1.13
Anomalous coronary arteries coursing between the aorta and pulmonary trunk: clinical indications for coronary artery bypass. Eur Heart J (1991) 1.12
Linkage disequilibrium at the Machado-Joseph disease/spinal cerebellar ataxia 3 locus: evidence for a common founder effect in French and Portuguese-Brazilian families as well as a second ancestral Portuguese-Azorean mutation. Am J Hum Genet (1995) 1.11
[Effect of amiodarone on cardiac rhythm and electrocardiograms]. Therapie (1972) 1.10
[Angiocardiographic diagnosis in right ventricular dysplasias]. Arch Mal Coeur Vaiss (1985) 1.10
Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism? Neurology (2007) 1.10
De novo expansion of intermediate alleles in spinocerebellar ataxia 7. Hum Mol Genet (1998) 1.09
CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. Brain (2001) 1.08
Clinical and molecular features of spinocerebellar ataxia type 6. Neurology (1997) 1.08
Spontaneous coronary artery dissection: case report and evidence for a defect in collagen metabolism. Eur Heart J (1986) 1.08
Close associations between prevalences of dominantly inherited spinocerebellar ataxias with CAG-repeat expansions and frequencies of large normal CAG alleles in Japanese and Caucasian populations. Am J Hum Genet (1998) 1.07
Arrhythmogenic right ventricular dysplasia: a clinical model for the study of chronic ventricular tachycardia. Jpn Circ J (1984) 1.06
Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation (1995) 1.06
Huntington's disease in French families: CAG repeat expansion and linkage disequilibrium analysis. C R Acad Sci III (1993) 1.05
[Electrocardiography of delayed potentials in post-excitation syndrome]. Arch Mal Coeur Vaiss (1978) 1.05
Are cognitive changes the first symptoms of Huntington's disease? A study of gene carriers. J Neurol Neurosurg Psychiatry (1998) 1.04
Recent advances in hereditary spastic paraplegia. Curr Opin Neurol (2001) 1.03
Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls. J Med Genet (2007) 1.02
[Cardiac involvement in Behçet's disease. 12 cases]. Presse Med (1988) 1.01
Molecular analyses of the LRRK2 gene in European and North African autosomal dominant Parkinson's disease. J Med Genet (2009) 1.01
Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation. Am J Hum Genet (2000) 1.01
Correlation between left ventricular hypertrophy and GAA trinucleotide repeat length in Friedreich's ataxia. Circulation (1997) 1.01
Autosomal-dominant cerebellar ataxia with retinal degeneration (ADCA type II) is genetically different from ADCA type I. Ann Neurol (1994) 0.99
Mapping of a new locus for autosomal recessive demyelinating Charcot-Marie-Tooth disease to 19q13.1-13.3 in a large consanguineous Lebanese family: exclusion of MAG as a candidate gene. Am J Hum Genet (2000) 0.98
Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia. Circulation (1992) 0.98
Decreased expression of the mitochondrial matrix proteases Lon and ClpP in cells from a patient with hereditary spastic paraplegia (SPG13). Neuroscience (2008) 0.98
Identification of VPS35 mutations replicated in French families with Parkinson disease. Neurology (2012) 0.98
Homozygosity in Huntington's disease. J Med Genet (1999) 0.97
EFNS/ENS Consensus on the diagnosis and management of chronic ataxias in adulthood. Eur J Neurol (2014) 0.97
Ventricular tachycardia catheter ablation in arrhythmogenic right ventricular dysplasia: a 16-year experience. Curr Cardiol Rep (2000) 0.97
Torsades de pointes: definition and management. Mod Concepts Cardiovasc Dis (1982) 0.97
[Permanent intra-hisian atrioventricular block induced during right intraventricular exploration]. Arch Mal Coeur Vaiss (1979) 0.97
Are (CTG)n expansions at the SCA8 locus rare polymorphisms? Nat Genet (2000) 0.96
Intracardiac conduction defects in dystrophia myotonica. Electrophysiological study of 12 cases. Br Heart J (1980) 0.95
Clinical and MRI findings in spinocerebellar ataxia type 5. Neurology (1999) 0.95
[18 F]-dopa PET study in patients with juvenile-onset PD and parkin gene mutations. Neurology (2000) 0.95
Beta-thalassemia: the Lebanese experience. Clin Lab Haematol (2006) 0.95
The gene for spinal cerebellar ataxia 3 (SCA3) is located in a region of approximately 3 cM on chromosome 14q24.3-q32.2. Am J Hum Genet (1995) 0.94
Oxidative stress in patients with unstable angina. Eur Heart J (1994) 0.94
Beta-globin gene cluster haplotypes and HbF levels are not the only modulators of sickle cell disease in Lebanon. Eur J Haematol (2003) 0.94
Striatal degeneration impairs language learning: evidence from Huntington's disease. Brain (2008) 0.94
Nuclear inclusions in spinocerebellar ataxia type 1. Acta Neuropathol (1999) 0.94
Pentanucleotide repeats at the spinocerebellar ataxia type 31 (SCA31) locus in Caucasians. Neurology (2011) 0.94
Emergency percutaneous coronary dilatation for acute myocardial infarction in Behçet's disease. Eur Heart J (1987) 0.93
Catatonia and Parkinsonism due to extrapontine myelinolysis following rapid correction of hyponatremia: a case report. J Neurol (2003) 0.93
bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma. J Pathol (1996) 0.92
Modern concepts of ventricular tachycardia. The value of electrocardiological investigations and delayed potentials in ventricular tachycardia of ischemic and nonischemic etiology (31 operated cases). Eur J Cardiol (1978) 0.92
Genome-wide scan linkage analysis for Parkinson's disease: the European genetic study of Parkinson's disease. J Med Genet (2004) 0.92
Genetic complexity and Parkinson's disease. Science (1997) 0.91
Intergenerational instability of the CAG repeat of the gene for Machado-Joseph disease (MJD1) is affected by the genotype of the normal chromosome: implications for the molecular mechanisms of the instability of the CAG repeat. Hum Mol Genet (1996) 0.91
[Significance of intraventricular conduction disorders observed in arrhythmogenic right ventricular dysplasia]. Arch Mal Coeur Vaiss (1984) 0.91
Endless-loop tachycardias: description and first clinical results of a new fully automatic protection algorithm. Pacing Clin Electrophysiol (1990) 0.90
Results of percutaneous catheter valvuloplasty for calcified aortic stenosis in the elderly. Eur Heart J (1987) 0.90
Incidence of thromboembolic events in Lebanese thalassemia intermedia patients. Thromb Haemost (2003) 0.90